NOBEL BIOCARE DANMARK A/S: Financial statements 2015
CVR: 28293364
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 5,513,299 and a net result of DKK 577,633 compared with DKK 429,847 the year before. That is an increase of 5.7% compared with the year before. Equity in the 2015 report amounted to DKK 2,961,068. The solvency ratio was 44%.
- Gross Profit
- DKK 5,513,299
- Profit/Loss
- DKK 577,633
- Equity
- DKK 2,961,068
- Total Assets
- DKK 6,735,276
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 5.5 mio. | 578 t. | 3 mio. | - |
| 2014 | - | 5.2 mio. | 430 t. | 2.4 mio. | - |
| 2013 | - | 5.3 mio. | 299 t. | 2 mio. | - |
| 2012 | - | 6.1 mio. | 409 t. | 4.7 mio. | - |
Official annual report
How creditworthy is NOBEL BIOCARE DANMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
NOBEL BIOCARE DANMARK A/S has published its annual report for 2014. Gross profit came to DKK 5,214,467, and the net result was DKK 429,847.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.